ELV Elevance Health Inc

  1. Stocks
  2. Healthcare
  3. NYSE: ELV

Price (delayed)

$400.32

Market cap

$86.82B

P/E Ratio

17.68

Dividend/share

$6.86

EPS

$22.64

Enterprise value

$107.63B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 42

Elevance Health is a lifetime, trusted health partner whose purpose is to improve the health of humanity. The company supports consumers, families, and communities across the entire healthcare journey – ...

Highlights
The company's revenue rose by 6% YoY
ELV's quick ratio is up by 4.5% since the previous quarter and by 4.5% year-on-year
Elevance Health's debt has increased by 2.8% YoY but it has decreased by 2.5% from the previous quarter
ELV's P/E is 25% above its last 4 quarters average of 14.1 and 2.8% above its 5-year quarterly average of 17.2
Elevance Health's net income has decreased by 7% YoY and by 5% QoQ
Sector: Healthcare
Industry: Healthcare Plans
Website: http://www.antheminc.com
Peers: OSCR PFG

Key stats

What are the main financial stats of ELV

ELV stock price

How has the Elevance Health stock price performed over time
Intraday
0.53%
1 week
1.55%
1 month
-6.2%
1 year
35.5%
YTD
14.2%
QTD
3.51%

Financial performance

How have Elevance Health's revenue and profit performed over time
Revenue
$201.11B
Gross profit
$30.41B
Operating income
$7.3B
Net income
$4.96B
Gross margin
15.1%
Net margin
2.5%
The operating margin has declined by 18% year-on-year and by 5% since the previous quarter
The operating income has contracted by 13% YoY and by 4.4% from the previous quarter
Elevance Health's net margin has decreased by 11% YoY and by 3.8% from the previous quarter
Elevance Health's net income has decreased by 7% YoY and by 5% QoQ

Price vs fundamentals

How does ELV's price correlate with its fundamentals

Growth

What is Elevance Health's growth rate over time

Valuation

What is Elevance Health stock price valuation
ELV P/E details
P/E
17.68
P/B
1.94
P/S
0.43
EV/EBIT
14.71
EV/EBITDA
12.19
EV/Sales
0.54
ELV's P/E is 25% above its last 4 quarters average of 14.1 and 2.8% above its 5-year quarterly average of 17.2
Elevance Health's EPS has decreased by 4.2% QoQ and by 4.2% YoY
ELV's price to book (P/B) is 25% lower than its 5-year quarterly average of 2.6 but 14% higher than its last 4 quarters average of 1.7
The equity has increased by 2.7% YoY and by 2.2% from the previous quarter
ELV's P/S is 28% below its 5-year quarterly average of 0.6 but 8% above its last 4 quarters average of 0.4
The company's revenue rose by 6% YoY

Efficiency

How efficient is Elevance Health business performance
Elevance Health's ROIC has decreased by 20% YoY and by 6% from the previous quarter
Elevance Health's return on sales has decreased by 18% YoY and by 5% QoQ
Elevance Health's return on assets has decreased by 11% YoY and by 7% QoQ
ELV's ROE is down by 10% YoY and by 7% QoQ

Dividends

What is ELV's dividend history
Dividend details
DPS
$6.86
Dividend yield
1.71%
Payout ratio
30.3%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Elevance Health financials performed over time
The total assets is 55% higher than the total liabilities
The current ratio rose by 6% YoY and by 2.7% QoQ
ELV's quick ratio is up by 4.5% since the previous quarter and by 4.5% year-on-year
Elevance Health's debt is 31% less than its equity
The debt to equity has declined by 5% since the previous quarter
The equity has increased by 2.7% YoY and by 2.2% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.